Sources | Names Used |
---|---|
GDSC1000 | KIN001-102 |
PharmacoGx | KIN001-102 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD3 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-08 |
mRNA | FUCA2 | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-08 |
mRNA | HIST1H3F | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-08 |
mRNA | CD6 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-08 |
mRNA | SLC25A29 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-08 |
mRNA | P4HA2 | GDSC1000 | pan-cancer | AAC | -0.21 | 4e-08 |
mRNA | THEM4 | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-08 |
mRNA | HADH | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
mRNA | TMEM158 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-08 |
mRNA | LCK | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |